Anna Kathy Aman

Array ( [id] => 5120588 [patent_doc_number] => 20070142303 [patent_country] => US [patent_kind] => A1 [patent_issue_date] => 2007-06-21 [patent_title] => 'Modulation of cell fates and activities by phthalazinediones' [patent_app_type] => utility [patent_app_number] => 11/699853 [patent_app_country] => US [patent_app_date] => 2007-01-30 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 0 [patent_figures_cnt] => 0 [patent_no_of_words] => 10166 [patent_no_of_claims] => 24 [patent_no_of_ind_claims] => 1 [patent_words_short_claim] => 0 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => publication [pdf_file] => publications/A1/0142/20070142303.pdf [firstpage_image] =>[orig_patent_app_number] => 11699853 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 5993610 [patent_doc_number] => 20110015263 [patent_country] => US [patent_kind] => A1 [patent_issue_date] => 2011-01-20 [patent_title] => 'THERAPEUTIC DELIVERY OF CARBON MONOXIDE' [patent_app_type] => utility [patent_app_number] => 12/223171 [patent_app_country] => US [patent_app_date] => 2007-01-23 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 4 [patent_figures_cnt] => 4 [patent_no_of_words] => 19515 [patent_no_of_claims] => 32 [patent_no_of_ind_claims] => 3 [patent_words_short_claim] => 0 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => publication [pdf_file] => publications/A1/0015/20110015263.pdf [firstpage_image] =>[orig_patent_app_number] => 12223171 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 5096148 [patent_doc_number] => 20070117757 [patent_country] => US [patent_kind] => A1 [patent_issue_date] => 2007-05-24 [patent_title] => 'Copolymer-1 improvements in compositions of copolymers' [patent_app_type] => utility [patent_app_number] => 11/656505 [patent_app_country] => US [patent_app_date] => 2007-01-23 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 2 [patent_figures_cnt] => 2 [patent_no_of_words] => 2286 [patent_no_of_claims] => 2 [patent_no_of_ind_claims] => 2 [patent_words_short_claim] => 0 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => publication [pdf_file] => publications/A1/0117/20070117757.pdf [firstpage_image] =>[orig_patent_app_number] => 11656505 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 8690016 [patent_doc_number] => 08389544 [patent_country] => US [patent_kind] => B2 [patent_issue_date] => 2013-03-05 [patent_title] => 'Isoquinolone compounds as subtype-selective agonists for melatonin receptors MT1 and MT2 ' [patent_app_type] => utility [patent_app_number] => 12/523532 [patent_app_country] => US [patent_app_date] => 2007-01-17 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 8 [patent_figures_cnt] => 8 [patent_no_of_words] => 11452 [patent_no_of_claims] => 20 [patent_no_of_ind_claims] => 6 [patent_words_short_claim] => 6 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => patent [pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 12523532 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 5220383 [patent_doc_number] => 20070161694 [patent_country] => US [patent_kind] => A1 [patent_issue_date] => 2007-07-12 [patent_title] => 'Use of indirubin as a dietary supplement' [patent_app_type] => utility [patent_app_number] => 11/652409 [patent_app_country] => US [patent_app_date] => 2007-01-10 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 0 [patent_figures_cnt] => 0 [patent_no_of_words] => 739 [patent_no_of_claims] => 17 [patent_no_of_ind_claims] => 1 [patent_words_short_claim] => 0 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => publication [pdf_file] => publications/A1/0161/20070161694.pdf [firstpage_image] =>[orig_patent_app_number] => 11652409 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 5410789 [patent_doc_number] => 20090124688 [patent_country] => US [patent_kind] => A1 [patent_issue_date] => 2009-05-14 [patent_title] => 'Prostaglandin reductase inhibitors' [patent_app_type] => utility [patent_app_number] => 11/650868 [patent_app_country] => US [patent_app_date] => 2007-01-08 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 0 [patent_figures_cnt] => 0 [patent_no_of_words] => 6549 [patent_no_of_claims] => 36 [patent_no_of_ind_claims] => 6 [patent_words_short_claim] => 0 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => publication [pdf_file] => publications/A1/0124/20090124688.pdf [firstpage_image] =>[orig_patent_app_number] => 11650868 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 4442414 [patent_doc_number] => 07928102 [patent_country] => US [patent_kind] => B2 [patent_issue_date] => 2011-04-19 [patent_title] => 'Irradiated compositions and treatment of cancers with radiation in combination with taurolidine and/or taurultam' [patent_app_type] => utility [patent_app_number] => 12/159875 [patent_app_country] => US [patent_app_date] => 2007-01-04 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 0 [patent_figures_cnt] => 0 [patent_no_of_words] => 8099 [patent_no_of_claims] => 14 [patent_no_of_ind_claims] => 2 [patent_words_short_claim] => 47 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => patent [pdf_file] => patents/07/928/07928102.pdf [firstpage_image] =>[orig_patent_app_number] => 12159875 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 4759964 [patent_doc_number] => 20080312190 [patent_country] => US [patent_kind] => A1 [patent_issue_date] => 2008-12-18 [patent_title] => 'Organophosphoric Derivatives Useful as Anti-Parasitic Agents' [patent_app_type] => utility [patent_app_number] => 12/158973 [patent_app_country] => US [patent_app_date] => 2006-12-22 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 0 [patent_figures_cnt] => 0 [patent_no_of_words] => 35156 [patent_no_of_claims] => 20 [patent_no_of_ind_claims] => 6 [patent_words_short_claim] => 0 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => publication [pdf_file] => publications/A1/0312/20080312190.pdf [firstpage_image] =>[orig_patent_app_number] => 12158973 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 5070250 [patent_doc_number] => 20070191352 [patent_country] => US [patent_kind] => A1 [patent_issue_date] => 2007-08-16 [patent_title] => 'Inhibition of tau-tau-association' [patent_app_type] => utility [patent_app_number] => 11/636628 [patent_app_country] => US [patent_app_date] => 2006-12-11 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 30 [patent_figures_cnt] => 30 [patent_no_of_words] => 17248 [patent_no_of_claims] => 7 [patent_no_of_ind_claims] => 2 [patent_words_short_claim] => 0 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => publication [pdf_file] => publications/A1/0191/20070191352.pdf [firstpage_image] =>[orig_patent_app_number] => 11636628 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 8220662 [patent_doc_number] => 20120134887 [patent_country] => US [patent_kind] => A1 [patent_issue_date] => 2012-05-31 [patent_title] => 'SEXUAL DYSFUNCTION' [patent_app_type] => utility [patent_app_number] => 12/096718 [patent_app_country] => US [patent_app_date] => 2006-12-08 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 3 [patent_figures_cnt] => 3 [patent_no_of_words] => 1590 [patent_no_of_claims] => 16 [patent_no_of_ind_claims] => 1 [patent_words_short_claim] => 0 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => publication [pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 12096718 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 6630401 [patent_doc_number] => 20100004335 [patent_country] => US [patent_kind] => A1 [patent_issue_date] => 2010-01-07 [patent_title] => 'ORAL PREPARATION FOR PREVENTING OR IMPROVING SKIN DRYNESS' [patent_app_type] => utility [patent_app_number] => 12/096347 [patent_app_country] => US [patent_app_date] => 2006-12-05 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 1 [patent_figures_cnt] => 1 [patent_no_of_words] => 2310 [patent_no_of_claims] => 3 [patent_no_of_ind_claims] => 3 [patent_words_short_claim] => 0 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => publication [pdf_file] => publications/A1/0004/20100004335.pdf [firstpage_image] =>[orig_patent_app_number] => 12096347 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 341694 [patent_doc_number] => 07501452 [patent_country] => US [patent_kind] => B2 [patent_issue_date] => 2009-03-10 [patent_title] => 'Treatment of xerostomia' [patent_app_type] => utility [patent_app_number] => 11/605983 [patent_app_country] => US [patent_app_date] => 2006-11-29 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 2 [patent_figures_cnt] => 2 [patent_no_of_words] => 7560 [patent_no_of_claims] => 23 [patent_no_of_ind_claims] => 1 [patent_words_short_claim] => 41 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => patent [pdf_file] => patents/07/501/07501452.pdf [firstpage_image] =>[orig_patent_app_number] => 11605983 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 5539914 [patent_doc_number] => 20090221719 [patent_country] => US [patent_kind] => A1 [patent_issue_date] => 2009-09-03 [patent_title] => 'BASE MATERIAL FOR PRODUCING FOOD AND FODDER' [patent_app_type] => utility [patent_app_number] => 12/095321 [patent_app_country] => US [patent_app_date] => 2006-11-23 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 0 [patent_figures_cnt] => 0 [patent_no_of_words] => 9824 [patent_no_of_claims] => 17 [patent_no_of_ind_claims] => 4 [patent_words_short_claim] => 0 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => publication [pdf_file] => publications/A1/0221/20090221719.pdf [firstpage_image] =>[orig_patent_app_number] => 12095321 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 6516319 [patent_doc_number] => 20100216831 [patent_country] => US [patent_kind] => A1 [patent_issue_date] => 2010-08-26 [patent_title] => 'DESLORATADINE CRYSTALLINE FORMS MIXTURES HAVING A LOW LEVEL OF RESIDUAL SOLVENTS' [patent_app_type] => utility [patent_app_number] => 11/917839 [patent_app_country] => US [patent_app_date] => 2006-11-17 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 0 [patent_figures_cnt] => 0 [patent_no_of_words] => 5446 [patent_no_of_claims] => 30 [patent_no_of_ind_claims] => 3 [patent_words_short_claim] => 0 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => publication [pdf_file] => publications/A1/0216/20100216831.pdf [firstpage_image] =>[orig_patent_app_number] => 11917839 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 4566202 [patent_doc_number] => 07846939 [patent_country] => US [patent_kind] => B2 [patent_issue_date] => 2010-12-07 [patent_title] => 'Salts and mixture of 9-oxoacridine-10-acetic acid with 1-alkylamino-1-desoxy-polyols, pharmaceutical compositions containing said agents and treatment methods' [patent_app_type] => utility [patent_app_number] => 12/094479 [patent_app_country] => US [patent_app_date] => 2006-11-17 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 0 [patent_figures_cnt] => 0 [patent_no_of_words] => 26214 [patent_no_of_claims] => 23 [patent_no_of_ind_claims] => 6 [patent_words_short_claim] => 18 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => patent [pdf_file] => patents/07/846/07846939.pdf [firstpage_image] =>[orig_patent_app_number] => 12094479 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 168496 [patent_doc_number] => 07666865 [patent_country] => US [patent_kind] => B2 [patent_issue_date] => 2010-02-23 [patent_title] => 'Calcium channel blockers' [patent_app_type] => utility [patent_app_number] => 11/601005 [patent_app_country] => US [patent_app_date] => 2006-11-16 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 4 [patent_figures_cnt] => 16 [patent_no_of_words] => 4590 [patent_no_of_claims] => 2 [patent_no_of_ind_claims] => 2 [patent_words_short_claim] => 26 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => patent [pdf_file] => patents/07/666/07666865.pdf [firstpage_image] =>[orig_patent_app_number] => 11601005 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 5570279 [patent_doc_number] => 20090253657 [patent_country] => US [patent_kind] => A1 [patent_issue_date] => 2009-10-08 [patent_title] => 'Use of Clodronic Acid for Treatment Podotrochlosis' [patent_app_type] => utility [patent_app_number] => 12/084587 [patent_app_country] => US [patent_app_date] => 2006-11-09 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 0 [patent_figures_cnt] => 0 [patent_no_of_words] => 1299 [patent_no_of_claims] => 7 [patent_no_of_ind_claims] => 1 [patent_words_short_claim] => 0 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => publication [pdf_file] => publications/A1/0253/20090253657.pdf [firstpage_image] =>[orig_patent_app_number] => 12084587 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 5304292 [patent_doc_number] => 20090298944 [patent_country] => US [patent_kind] => A1 [patent_issue_date] => 2009-12-03 [patent_title] => 'PHARMACEUTICAL COMPOSITION' [patent_app_type] => utility [patent_app_number] => 12/097453 [patent_app_country] => US [patent_app_date] => 2006-11-09 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 0 [patent_figures_cnt] => 0 [patent_no_of_words] => 4829 [patent_no_of_claims] => 11 [patent_no_of_ind_claims] => 4 [patent_words_short_claim] => 0 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => publication [pdf_file] => publications/A1/0298/20090298944.pdf [firstpage_image] =>[orig_patent_app_number] => 12097453 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 4451312 [patent_doc_number] => 07964636 [patent_country] => US [patent_kind] => B2 [patent_issue_date] => 2011-06-21 [patent_title] => 'Synthesis and use of novel inhibitors and inactivators of protein arginine deiminases' [patent_app_type] => utility [patent_app_number] => 12/092627 [patent_app_country] => US [patent_app_date] => 2006-11-07 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 24 [patent_figures_cnt] => 24 [patent_no_of_words] => 15341 [patent_no_of_claims] => 24 [patent_no_of_ind_claims] => 5 [patent_words_short_claim] => 11 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => patent [pdf_file] => patents/07/964/07964636.pdf [firstpage_image] =>[orig_patent_app_number] => 12092627 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 5051922 [patent_doc_number] => 20070032467 [patent_country] => US [patent_kind] => A1 [patent_issue_date] => 2007-02-08 [patent_title] => 'Method for treating hyperlipidemia' [patent_app_type] => utility [patent_app_number] => 11/546248 [patent_app_country] => US [patent_app_date] => 2006-10-12 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 1 [patent_figures_cnt] => 1 [patent_no_of_words] => 2250 [patent_no_of_claims] => 2 [patent_no_of_ind_claims] => 2 [patent_words_short_claim] => 0 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => publication [pdf_file] => publications/A1/0032/20070032467.pdf [firstpage_image] =>[orig_patent_app_number] => 11546248 [rel_patent_id] =>[rel_patent_doc_number] =>)